FMS
Fresenius Medical Care Corporation
NYSE: FMS · HEALTHCARE · MEDICAL CARE FACILITIES
$21.76
+0.46% today
Updated 2026-06-05
Market cap
$12.00B
P/E ratio
11.89
P/S ratio
0.62x
EPS (TTM)
$1.88
Dividend yield
3.90%
52W range
$19 – $28
Volume
0.8M
WallStSmart proprietary scores
50
out of 100
Grade: C
Hold
Investment rating
2.7
Growth
F6.0
Quality
B5.0
Profitability
C+9.3
Valuation
A+6/9
Piotroski F-Score
Moderate
2.0
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$26.54
+21.97%
12-Month target
$27.98
+28.58%
Intrinsic (DCF)
$77.65
Margin of safety
+69.03%
0 Strong Buy2 Buy3 Hold1 Sell1 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $36.82M — positive
+ 69.03% below intrinsic value
Risks
- Thin margins at 4.88%
- Revenue declining -5.50% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $19.40B | $19.45B | $19.34B | $19.63B | $19.36B |
| Net income | $673.40M | $499.00M | $537.91M | $978.37M | $117.53M |
| EPS | — | — | — | — | $1.88 |
| Free cash flow | $756.00M | $1.94B | $1.69B | $1.70B | $36.82M |
| Profit margin | 3.47% | 2.57% | 2.78% | 4.98% | 4.88% |
Peer comparison
Smart narrative
Fresenius Medical Care Corporation trades at $21.76. representing a P/E of 11.89x trailing earnings. Our Smart Value Score of 50/100 indicates the stock is fair. The company scores 6/9 on the Piotroski F-Score. With an Altman Z-Score of 1.96, it sits in the grey zone. TTM revenue stands at $19.36B. with profit margins at 4.88%. Our DCF model estimates intrinsic value at $77.65.
Frequently asked questions
What is Fresenius Medical Care Corporation's stock price?
Fresenius Medical Care Corporation (FMS) trades at $21.76, on a P/E of 11.9x and a P/S of 0.6x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Fresenius Medical Care Corporation overvalued?
Fresenius Medical Care Corporation carries a Smart Value Score of 50/100 (Grade C), which we rate Hold. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $77.65 versus the $21.76 price, a 69.0% margin of safety on a cash flow basis.
What is the price target of Fresenius Medical Care Corporation (FMS)?
The 12-month analyst consensus target is $26.54, about 22.0% above the current $21.76. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the future stock price of FMS by 2030?
Our research-backed model puts the 2030 base case at $21.71, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.
What is the intrinsic value of Fresenius Medical Care Corporation (FMS)?
Our DCF model estimates intrinsic value at $77.65, a +69.0% margin of safety versus today's $21.76. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is Fresenius Medical Care Corporation's revenue?
Fresenius Medical Care Corporation's trailing twelve-month revenue is $19.36B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Fresenius Medical Care Corporation's Altman Z-Score is 1.96, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.62x
ROE7.13%
Beta0.81
50D MA$22.23
200D MA$23.73
Shares out0.54B
Float0.37B
Short ratio—
Avg volume0.8M
Performance
1 week+0.00%
1 month+6.10%
3 months-0.40%
YTD-7.51%
1 year—
3 years—
5 years—